A recent study reported that the GC content in serum of breast cancer patients with metastasis is significantly higher than in non-metastatic breast cancer patients, with increased ROR1 expression and Wnt pathway activation induced by GR activation-mediated breast cancer metastasis [15], which was also found from our transcriptome sequencing results. This evidence concerns the gene NR3C1 and breast carcinoma.